Social Media Regulatory Affairs Summit Presentations


Click on the presentation title to download the presentation.

Wednesday, June 24, 2015

9:15 a.m. – 9:45 a.m.

Welcome and Overview: The Social Media and Pharma — Key Challenges for Industry

Dale Cooke, President, Philly Cooke Consulting

9:45 a.m. – 10:45 a.m.

Working with Patient Communities

Brian Loew, CEO, Inspire and
Monica Smith, Executive Director, Bladder Cancer Advocacy Network

11:00 a.m. – 12:00 p.m.

Regulatory Issues with Social Media - Beyond the FDA

Lindsay Tonsager, Associate, Covington & Burling LLP

1:00 p.m. – 2:00 p.m.

Recruiting for Clinical Trials via Social Media

Chris Trizna, President, CSSi

2:00 p.m. – 3:00 p.m.

Ten Social Pitfalls to Avoid

Dale Cooke, President, Philly Cooke Consulting

3:15 p.m. – 4:15 p.m.

Getting to Yes — The Path to Satisfying Both ROI and FDA

Doug Weinbrenner, Director, Social Media, Intouch Solutions

4:15 p.m. – 5:30 p.m.

Pharma’s Social Media Rubik’s Cube: A Hands-on Solution

Phil Baumann, RN BSN, Social Media Strategist, Telerx

 

Thursday, June 25, 2015

9:00 a.m. – 9:30 a.m.

FDA’s Approach to Social Media

David Adams, Partner, Venable - Former FDA Associate Chief Counsel; Director, Policy Development and Coordination Staff

9:30 a.m. – 10:00 a.m.

Developing a Social Media Policy

Kristen R. Klesh, Esq., Associate, Venable LLP

10:00 a.m. – 10:45 a.m.

The Challenge to Industry to Embrace Social Media

Peter Pitts, President, Center for Medicine in the Public Interest

11:00 a.m. – 12:00 p.m.

Correcting Misinformation: Should You Do It and How

Bradley Merrill Thompson, Member, Epstein, Becker & Green

1:00 p.m. – 2:00 p.m.

Adverse Event Reporting and Social Media

Anne V. Maher, Partner, Kleinfield Kaplan & Becker

2:00 p.m. – 3:00 p.m.

Off-Label Promotion – Social Media Pitfalls

Alan Minsk, Partner, Arnall Golden Gregory

3:15 p.m. – 4:30 p.m.

Panel — Industry Attitudes and Barriers to Adoption of Social Media (No slides for this session)

Moderator: Peter Pitts, President, Center for Medicine in the Public Interest, Moderator

Panelists:

  • David Adams, Partner, Venable - former FDA Associate Chief Counsel; Director, Policy Development and Coordination Staff
  • Torrey Cope, Partner, Sidley Austin LLP